drugset / Trial / NCT04604587
MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA
NaSingle-groupOpen-labelDiagnostic
Summary
In this three-year proposal, we will explore the MRI-visible EPVS in CAA and investigate its pathophysiology using animal models. Our specific aims include: (1) Establish the relationship of MRI-visible enlarged perivascular space and CAA, (2) Determine whether vascular amyloid clearance in CAA is associated with lymphatic drainage system, (3) Establish longitudinal data for MRI-visible enlarged perivascular space and cerebral amyloid angiopathy progression.
Timeline
- Start
- 2020-10-08
- Primary completion
- 2023-07-31
- Completion
- 2023-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 11C-PiB | Diagnostic / imaging agent | 10 unknown | — |
| Subject | florbetapir F 18 | Diagnostic / imaging agent | 10 unknown | — |